TAGRISSO® (OSIMERTINIB) PLUS CHEMOTHERAPY DEMONSTRATED STATISTICALLY SIGNIFICANT AND CLINICALLY MEANINGFUL IMPROVEMENT IN OVERALL SURVIVAL IN EGFR-MUTATED ADVANCED LUNG CANCER

Reuters · 07/21 11:00

Please log in to view news